Medicine and Dentistry
Concanavalin A
100%
Autoimmune Hepatitis
36%
T-Helper Cell
27%
Farnesyltransferase Inhibitor
27%
Phosphorylation
18%
Interferon
18%
Natural Killer T Cell
18%
Alanine Aminotransferase
18%
Interferon Production
18%
Cells
9%
Tumor Necrosis Factor
9%
Plasma
9%
Therapeutic Procedure
9%
In Vitro
9%
Liver Transplantation
9%
Protein
9%
Serum
9%
Intraperitoneal Drug Administration
9%
T Cell Activation
9%
Phosphate Buffered Saline
9%
Intravenous Drug Administration
9%
Injection
9%
Liver Injury
9%
Cytotoxic T-Cell
9%
Interleukin 6
9%
Hepatitis
9%
Spleen
9%
Biochemistry, Genetics and Molecular Biology
Concanavalin A
100%
T Cell
36%
CD4
36%
Mouse
27%
Farnesyltransferase
27%
CD8
18%
Phosphorylation
18%
Interferon
18%
STAT1
18%
Interferon Production
18%
Natural Killer T Cell
18%
Protein
9%
Tumor Necrosis Factors
9%
Interleukin 6
9%
Cell Activation
9%
Phosphate Buffered Saline
9%
Alanine Aminotransferase Level
9%
Alanine Aminotransferase Blood Level
9%
Pharmacology, Toxicology and Pharmaceutical Science
Concanavalin A
100%
Tipifarnib
100%
Autoimmune Hepatitis
36%
Mouse
27%
Protein Farnesyltransferase Inhibitor
27%
Interferon
18%
Alanine Aminotransferase
18%
Interleukin 6
9%
Protein
9%
Liver Injury
9%
Tumor Necrosis Factor
9%
Intraperitoneal Injection
9%
Hepatitis
9%
Phosphate Buffered Saline
9%
Veterinary Science and Veterinary Medicine
Autoimmune Hepatitis
36%
Liver
27%
STAT1
18%
Natural Killer T Cell
18%
CD4
9%
Hepatitis
9%